EUVIMEDEUVIMED entdecken
Crossref

ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?

D. Hao, S. Narang, Y Eshraghi

ASRA News · 01.05.2026 · 51 (2)

DOI: 10.52211/asra050126.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASRA News, online erschienen am 01.05.2026. Verfasst von D. Hao und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hao, D., Narang, S., & Eshraghi, Y. (2026). ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?. ASRA News, 51(2). https://doi.org/10.52211/asra050126.005

Vancouver

Hao D, Narang S, Eshraghi Y. ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?. ASRA News. 2026;51(2). doi:10.52211/asra050126.005

BibTeX
@article{Hao2026,
  author = {Hao, D. and Narang, S. and Eshraghi, Y},
  title = {ASRA answers: how long should chemotherapy be delayed after an intrathecal pump implant in a cancer patient?},
  journal = {ASRA News},
  year = {2026},
  volume = {51},
  number = {2},
  doi = {10.52211/asra050126.005}
}
Kostenlos starten →